Apparatuses and methods for wound therapy
US-2016166744-A1 · Jun 16, 2016 · US
US12324728B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12324728-B2 |
| Application number | US-202217861074-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 8, 2022 |
| Priority date | Oct 26, 2017 |
| Publication date | Jun 10, 2025 |
| Grant date | Jun 10, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An apparatus for filling a wound can include an array of at least four truncated ellipsoids interconnected to define at least one fluid path through, for example perpendicular to, the array. The longest principal axis of each ellipsoid may be perpendicular to the array. Each truncated ellipsoid may be a spheroid and/or may include an approximately elliptical contact surface at each contact surface between two interconnected ellipsoids. Each fluid pathway may have four continuously-curved concave sides and may have a parallelogram-shaped cross-section with continuously-curved concave edges. A dressing may include the apparatus, a dressing layer coupled to the apparatus, a backing layer disposed over a surface of the dressing layer opposite the apparatus, and an attachment device disposed on at least a margin of the backing layer. Methods of treating various tissue sites using the apparatus or dressing with negative-pressure therapy are also disclosed.
Opening claim text (preview).
What is claimed is: 1. An apparatus for filling a wound, the apparatus comprising: an array of interconnected polymeric ovules having a truncated ellipsoidal shape, wherein: each set of four interconnected ovules defines a fluid pathway extending perpendicularly through the array; each truncated ellipsoidal shape comprises an approximately elliptical contact surface at each contact surface between two interconnected ovules; and each interconnected polymeric ovule has its longest principal axis oriented substantially perpendicular to the array. 2. The apparatus of claim 1 , wherein the array comprises: at least three columns comprising two edge columns and at least one central column; and at least three rows comprising two edge rows and at least one central row, and wherein each set of four interconnected ovules is arranged in two of the at least three rows and two of the at least three columns. 3. The apparatus of claim 1 , wherein the array comprises four corner ovules, at least four edge ovules, at least one central ovule, and at least four fluid pathways interstitially therebetween, each central ovule having a truncated ellipsoidal shape with four elliptical contact surfaces, each edge ovule having a truncated ellipsoidal shape with three elliptical contact surfaces, and each corner ovule having a truncated ellipsoidal shape with two elliptical contact surfaces. 4. The apparatus of claim 1 , wherein the interconnected ovules are comprised of a polyolefin, a polyester, a polyamide, a polystyrene, a polydiolefin, a polyacrylonitrile, a polysiloxane, or a copolymer or combination thereof. 5. The apparatus of claim 1 , wherein each interconnected ovule has its two principal axes other than the longest principal axis, respectively, oriented at approximately a 45° angle to a row direction of the array and at approximately a 45° angle to a column direction of the array. 6. The apparatus of claim 1 , wherein each of the interconnected ovules are truncated only at one end of the longest principal axis and at each surface where the ovules are interconnected. 7. The apparatus of claim 1 , wherein the array of interconnected ellipsoids or interconnected ovules has an upper surface and a lower surface, and wherein the upper surface or the lower surface or both has a hardness from about 0 Shore A to about 25 Shore A. 8. The apparatus of claim 7 , wherein the upper surface or the lower surface or both has a coating disposed thereon that exhibits a hardness of at least 55 Shore A. 9. The apparatus of claim 8 , wherein the coating is comprised of a cellulosic material, a polyester, a polyamide, a polycarbonate, a perhalogenated polyolefin, an aramid, a polybenzimidazole, a polysulfone, or a copolymer, combination, or cross-linked gel thereof. 10. The apparatus of claim 1 , wherein at least a portion of the interconnected ellipsoids or at least a portion of the interconnected ovules comprise one or more grooves on an outer surface of each ellipsoid or of each ovule that extend at least partially in a direction of its longest principal axis. 11. The apparatus of claim 10 , wherein each groove has an average depth no more than 30% of a diameter of each interconnected ovule or of each interconnected ellipsoid along a principal axis direction other than the longest principal axis. 12. The apparatus of claim 1 , wherein a longest principal axis of each interconnected ellipsoid or each interconnected ovule is from about 3 mm to about 6 mm. 13. The apparatus of claim 12 , wherein each principal axis other than the longest principal axis of each interconnected ellipsoid or each interconnected ovule is from about 2 mm to about 4 mm. 14. The apparatus of claim 1 , wherein each fluid pathway has a minimum width dimension from about 500 microns to about 1500 microns. 15. The apparatus of claim 1 , wherein the apparatus is translucent. 16. The apparatus of claim 1 , further comprising a wound healing agent in or on the array, the wound healing agent comprising a non-steroidal anti-inflammatory drug, a steroid, an anti-inflammatory cytokine, an anaesthetic, an antiseptic, an antimicrobial agent, a growth factor, a peptide, a microRNA, an antioxidant, or a combination thereof. 17. The apparatus of claim 16 , wherein the antimicrobial agent comprises silver, a silver salt, a tetracycline, a beta-lactam, a macrolide, an aminoglycoside, a fluoroquinolone, a cellulose ethyl sulfonate, or a combination thereof.
characterised by the structure of the dressing · CPC title
with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants (for negative pressure wound therapy A61M1/92, A61M1/94; combined with tracheal tubes A61M16/0463; dental instruments with combined rinsing and aspirating A61C17/0208) · CPC title
Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing · CPC title
with liquid supply means · CPC title
Constructional details of the pressure distribution manifold · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.